Date: 31-Aug-2019

Patent court to review Alexions Soliris patents on Amgen challenge

By Manas Mishra and Manojna Maddipatla The U.S. patent office will review patents on Alexion Pharmaceuticals Incs blood disorder treatment Soliris, after Amgen Inc challenged them, court filings showed on Friday.